Projects per year
Fingerprint
Dive into the research topics where Barry Kreiswirth is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A dual-beta-lactam strategy for treating multidrug resistant M abscessus
National Institute of Allergy and Infectious Diseases
8/15/19 → 7/31/22
Project: Research project
-
Center to develop innovative therapeutics to multidrug resistant high-threat bacterial agents
Perlin, D., Dartois, V., Kreiswirth, B., Ebright, R., Brady, S., Roemer, T., Dick, T. & Alland, D.
National Institute of Allergy and Infectious Diseases
5/1/19 → 4/30/22
Project: Research project
-
Unraveling colistin resistance in Klebsiella pneumoniae
National Institute of Allergy and Infectious Diseases
1/15/18 → 12/31/20
Project: Research project
-
A rapid molecular approach to determine PZA susceptibility
National Institute of Allergy and Infectious Diseases
6/1/13 → 5/31/15
Project: Research project
-
The molecular basis of the carbapenem resistance epidemic
National Institute of Allergy and Infectious Diseases
3/15/11 → 11/30/21
Project: Research project
Research output
-
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
Multi-Drug Resistant Organism Network Investigators, Mar 2022, In: The Lancet infectious diseases. 22, 3, p. 401-412 12 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on b-Lactam Susceptibility
Kurepina, N., Chen, L., Composto, K., Rifat, D., Nuermberger, E. L. & Kreiswirth, B. N., Apr 2022, In: Antimicrobial agents and chemotherapy. 66, 4Research output: Contribution to journal › Article › peer-review
-
Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane b-Lactamase Inhibitor To Augment b-Lactam Action
Dousa, K. M., Nguyen, D. C., Kurz, S. G., Taracila, M. A., Bethel, C. R., Schinabeck, W., Kreiswirth, B. N., Brown, S. T., Henry Boom, W., Hotchkiss, R. S., Remy, K. E., Jacono, F. J., Daley, C. L., Holland, S. M., Miller, A. A. & Bonomo, R. A., Feb 1 2022, In: mBio. 13, 1, e03529.Research output: Contribution to journal › Article › peer-review
-
Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients
Nguyen, M. H., Shields, R. K., Chen, L., William Pasculle, A., Hao, B., Cheng, S., Sun, J., Kline, E. G., Kreiswirth, B. N. & Clancy, C. J., Feb 1 2022, In: Clinical Infectious Diseases. 74, 3, p. 395-406 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii
for the Antibacterial Resistance Leadership Group (ARLG), Feb 2021, In: Diagnostic Microbiology and Infectious Disease. 99, 2, 115242.Research output: Contribution to journal › Article › peer-review
7 Scopus citations